相关实验视频
Updated: Jun 12, 2025

13:13
Biochemical Measurement of Neonatal Hypoxia
Published on: August 24, 2011
14.0K
药物诱导的高血清性血.
Chaker Ben Salem1, Myriam Agrebi2, Dhouha Sahnoun2
1Clinical Pharmacology, Pharmacovigilance Center of Sousse, Faculty of Medicine of Sousse, University of Sousse, Street Mohamed Karoui, 4002, Sousse, Tunisia. bensalem.c@gmail.com.
Drug safety
|September 17, 2024
概括
血清尿酸过低或血清尿酸过低的原因可能是药物. 本综述总结了降低尿酸水平的药物,它们的机制和临床重要性.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 血清尿酸含量低于2.0 mg/dL的血清尿酸水平被定义为血清尿酸含量低于2.0 mg/dL.
- 它可能是各种疾病的结果,包括肝病,癌症和尿酸再吸收受损.
- 药物是高血压的重要原因之一,而且常常被忽视.
研究的目的:
- 审查和总结可以诱导高血压的药物.
- 阐明药物降低尿酸水平的作用机制.
- 讨论药物诱导的高血的临床意义.
主要方法:
- 关于高血糖和药物研究的文献综述.
- 对影响尿酸代谢和分泌的药物机制的分析.
- 对药物诱导的高血的临床数据的综合.
主要成果:
- 药物诱导的高尿血常常是由于过度治疗高尿血症而导致的.
- 丁氧化酶抑制剂,尿酸剂和尿酸是常见的罪祸首.
- 不主要用于痛风治疗的药物也可以降低血清尿酸水平.
结论:
- 药物是高血压的关键原因,需要在临床实践中仔细考虑.
- 了解药物机制是管理高血的关键.
- 进一步的研究可能会澄清各种药物诱导的高血病例的临床影响.
相关概念视频
Antihypertensive Drugs: Action of Diuretics
629
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
629
Renal Failure: Dose Adjustments
68
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
68
Oral Hypoglycemic Agents: Sulfonylureas
196
Sulfonylureas are oral hypoglycemic agents utilized in treating type 2 diabetes. They are characterized by their unique sulfonylurea chemical structure. The family of sulfonylureas is divided into generations. First-generation sulfonylureas, including tolbutamide (Orinase), chlorpropamide (Diabinese), and tolazamide (Tolinase), trigger insulin release from pancreatic β cells and enhance peripheral tissues' insulin sensitivity. The second-generation members, such as glipizide...
196
Enhanced Elimination of Poison
486
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
486
Hypoglycemia and Glucagon
207
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
207
Oral Hypoglycemic Agents: Biguanides and Glitazones
182
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
182

